Effect of Rosuvastatin on Coronary Atheroma in diffused Coronary Artery Disease

Effect of rosuvastatin on coronary atheroma in diffused coronary artery disease: a multicenter coronary atherosclerosis study using intravascular ultrasound and angiography

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10001085

Enrollment

Unknown

Registered

2010-10-22

Start date

2011-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffused Coronary Artery Disease

Interventions

A:Rosuvastatin

B:Atorvastatin

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Diffused coronary artery disease confirmed by gngiography

Exclusion criteria

Exclusion criteria: 1. BMI>=30Kg/m2; 2. Allergy to Rosuvastatin; 3. LDL-C 10%; 5. uncontrolled hypertension; 6. administration of cyclosporine; 7. secondary hyperlipidemia; 8. creatinine clearance2mg/dl; 9. addiction of alcohol.

Design outcomes

Primary

Measure	Time frame
coronary artery stenosis;coronary atherom;	—

Secondary

Measure	Time frame
arrhythmia and ischemia;heart function;arrhythmia and ischemia;heart attach;	—

Countries

China

Contacts

Public ContactXiaohui Zhao

zxhwn2002@yahoo.com.cn+86 023 68774569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026